Next generation T-cell engineering with ArsenalBio

Co-founder, Chairman & CEO Ken Drazan explains the array of applications that Arsenal engineers into its CAR-T cells and describes how it is done with a single gene modification at one location, and then V.P. Brendan Galvin takes us on a tour of the company's facilities.